In spine surgery, the newest wave in motion preservation is dynamic or flexible stabilization. Applied Spine Technologies, with a license to technology developed by the man that wrote the bible on spine biomechanics, Manonhar Panjabi, hopes to offer the market an alternative to fusion that allows normal physiologic motion.
300 George Street, Suite 511
New Haven, CT 06511
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
Eye drug is already in Phase III trials elsewhere, with results due in Q3. Nicox could earn up to a further €24.5m in milestones and royalties from Kowa alliance.
Spero and partner GSK have Phase III non-inferiority data to support approval of tebipenem as the first oral antibiotic for complicated urinary tract infections.
CEO Matt Gline talked to Scrip in an interview about dealmaking and the road back to commercialization.
Sevabertinib gets onto the FDA's approval fast track three months after zongertinib.
CEO Matt Gline talked to Scrip in an interview about dealmaking and the road back to commercialization.
Sevabertinib gets onto the FDA's approval fast track three months after zongertinib.
A study of the German biotech's intravenous complement factor C5a antibody for pyoderma gangrenosum was stopped for futility.
